Johnson Matthey (OTCMKTS:JMPLY) Lifted to Buy at Zacks Investment Research


Share on StockTwits

Johnson Matthey (OTCMKTS:JMPLY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Wednesday, Zacks.com reports. The brokerage currently has a $95.00 price target on the basic materials company’s stock. Zacks Investment Research‘s price objective suggests a potential upside of 10.57% from the stock’s previous close.

According to Zacks, “Johnson Matthey Plc is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Its principal activities comprise manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients. The Company also engages in the marketing, refining, and fabrication of precious metals. Its environmental technologies include emission control technologies, process technologies and fuel cells. Its precious metals products include platinum, noble metals, catalysts, chemicals and refining and colour technologies. Its fine chemicals include macfarlan smith, pharmaceutical materials and services and research chemicals. Johnson Matthey Plc is headquartered in London, U.K. “

Several other equities research analysts have also weighed in on JMPLY. Morgan Stanley reissued an “overweight” rating on shares of Johnson Matthey in a report on Friday, February 5th. Credit Suisse Group reaffirmed an “outperform” rating on shares of Johnson Matthey in a report on Wednesday, March 10th. Stifel Nicolaus reiterated a “hold” rating on shares of Johnson Matthey in a research report on Tuesday, March 9th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Johnson Matthey in a research report on Tuesday, March 2nd. Finally, Jefferies Financial Group started coverage on Johnson Matthey in a research report on Monday, March 29th. They set a “buy” rating for the company. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $95.00.

JMPLY traded up $0.97 during trading hours on Wednesday, hitting $85.92. The stock had a trading volume of 2,245 shares, compared to its average volume of 1,792. The company’s fifty day simple moving average is $87.02 and its 200 day simple moving average is $72.41. Johnson Matthey has a 1 year low of $44.21 and a 1 year high of $94.45. The stock has a market cap of $8.31 billion, a PE ratio of 16.95, a price-to-earnings-growth ratio of 6.11 and a beta of 1.58.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Story: Management Fee

Get a free copy of the Zacks research report on Johnson Matthey (JMPLY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Johnson Matthey (OTCMKTS:JMPLY)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.